Shingrix shortage: Advice for physicians

With demand for the newer shingles vaccine, known as Shingrix, far outstripping the pace at which the manufacturer can supply it, shortages will likely continue throughout 2019, predicts the CDC.   “GlaxoSmithKline [GSK] are running their vaccine plants as much as they can, to produce more but it’s just not enough,” says Julio Viola, PharmD, the director of centralized pharmacy services at Northwell Health Systems, which operate in the New York metro area. 
Source: ConsultantLive - Category: Internal Medicine Authors: Tags: Medical News Source Type: news

Related Links:

This article highlights practical considerations to help clinicians appropriately apply the most recent vaccine recommendations to their patients.
Source: The Nurse Practitioner - Category: Nursing Tags: Feature: IMMUNIZATIONS Source Type: research
NEW YORK (Reuters Health)—The recombinant shingles vaccine (RZV) is associated with an increased risk of gout flare, and a new study suggests other vaccines may trigger flares as well, researchers say. “Our findings are novel because for the first time, we have identified a trigger for gout flares that presumably acts through [an inflammatory] pathway,... [Read More]
Source: The Rheumatologist - Category: Rheumatology Authors: Tags: Conditions Crystal Arthritis Source Type: research
The recombinant shingles vaccine (RZV) is associated with an increased risk of gout flare, and a new study suggests other vaccines may trigger flares as well, researchers say.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Rheumatology News Source Type: news
Conditions:   Zoster;   Zoster Varicella;   Shingles;   Chicken Pox Intervention:   Biological: Shingrix® Sponsors:   Emory University;   National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting
Source: - Category: Research Source Type: clinical trials
This Medical News article examines the increasing incidence of herpes zoster ophthalmicus —shingles of the eye—and the need for more widespread vaccination against shingles.
Source: JAMA - Journal of the American Medical Association - Category: General Medicine Source Type: research
Too late for the vaccine to prevent the painful nerve condition, I had to focus on long-term treatment.
Source: Washington Post: To Your Health - Category: Consumer Health News Authors: Source Type: news
Shingles and meningitis treatments help offset blow from generic version of key drug
Source: - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
Abstract Varicella zoster and herpes zoster are infections caused by the highly contagious varicella-zoster virus (VZV). Despite widespread availability of vaccines against VZV, as well as varicella vaccination rates>95%, VZV remains a public health concern because of several common myths and misconceptions. Because of the success of routine varicella vaccination programs, some people mistakenly believe that varicella and herpes zoster are now no longer a threat to public health. Another common misconception is that shingles is less infectious than varicella; however, clinical evidence indicates otherwise. Seve...
Source: Clinical Therapeutics - Category: Drugs & Pharmacology Authors: Tags: Clin Ther Source Type: research
More News: Internal Medicine | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines